{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Pléthysmographie : Questions médicales les plus fréquentes",
"headline": "Pléthysmographie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Pléthysmographie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-23",
"dateModified": "2025-03-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Pléthysmographie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Techniques de diagnostic cardiovasculaire",
"url": "https://questionsmedicales.fr/mesh/D003935",
"about": {
"@type": "MedicalCondition",
"name": "Techniques de diagnostic cardiovasculaire",
"code": {
"@type": "MedicalCode",
"code": "D003935",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E01.370.370"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Photopléthysmographie",
"alternateName": "Photoplethysmography",
"url": "https://questionsmedicales.fr/mesh/D017156",
"about": {
"@type": "MedicalCondition",
"name": "Photopléthysmographie",
"code": {
"@type": "MedicalCode",
"code": "D017156",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E01.370.370.610.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cardiographie d'impédance",
"alternateName": "Cardiography, Impedance",
"url": "https://questionsmedicales.fr/mesh/D002307",
"about": {
"@type": "MedicalCondition",
"name": "Cardiographie d'impédance",
"code": {
"@type": "MedicalCode",
"code": "D002307",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E01.370.370.610.610.200"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Pléthysmographie",
"alternateName": "Plethysmography",
"code": {
"@type": "MedicalCode",
"code": "D010991",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Paul Muntean",
"url": "https://questionsmedicales.fr/author/Paul%20Muntean",
"affiliation": {
"@type": "Organization",
"name": "Department of Functional Sciences, \"Victor Babeș\" University of Medicine and Pharmacy of Timișoara, 300041 Timisoara, Romania."
}
},
{
"@type": "Person",
"name": "Adrian Neagu",
"url": "https://questionsmedicales.fr/author/Adrian%20Neagu",
"affiliation": {
"@type": "Organization",
"name": "Department of Functional Sciences, \"Victor Babeș\" University of Medicine and Pharmacy of Timișoara, 300041 Timisoara, Romania."
}
},
{
"@type": "Person",
"name": "Monica Neagu",
"url": "https://questionsmedicales.fr/author/Monica%20Neagu",
"affiliation": {
"@type": "Organization",
"name": "Department of Functional Sciences, \"Victor Babeș\" University of Medicine and Pharmacy of Timișoara, 300041 Timisoara, Romania."
}
},
{
"@type": "Person",
"name": "Bianka Schulz",
"url": "https://questionsmedicales.fr/author/Bianka%20Schulz",
"affiliation": {
"@type": "Organization",
"name": "Clinic of Small Animal Medicine, LMU University of Munich, Munich, Germany."
}
},
{
"@type": "Person",
"name": "Anca Popa",
"url": "https://questionsmedicales.fr/author/Anca%20Popa",
"affiliation": {
"@type": "Organization",
"name": "Department of Functional Sciences, \"Victor Babeș\" University of Medicine and Pharmacy of Timișoara, 300041 Timisoara, Romania."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Assessment of diagnostic value of unilateral systematic biopsy combined with targeted biopsy in detecting clinically significant prostate cancer.",
"datePublished": "2024-10-04",
"url": "https://questionsmedicales.fr/article/39381426",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/med-2024-1048"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblast-secreted exosomes promote prostate cancer cell migration and invasion by the FGL1/SOX5 axis.",
"datePublished": "2024-10-02",
"url": "https://questionsmedicales.fr/article/39463328",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14670/HH-18-826"
}
},
{
"@type": "ScholarlyArticle",
"name": "18β-Glycyrrhetinic acid synergizes with enzalutamide to counteract castration-resistant prostate cancer by inhibiting OATP2B1 uptake of dehydroepiandrosterone.",
"datePublished": "2024-09-12",
"url": "https://questionsmedicales.fr/article/39277096",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejphar.2024.176995"
}
},
{
"@type": "ScholarlyArticle",
"name": "The impact of integrating PRIMARY score or SUVmax with MRI-based risk models for the detection of clinically significant prostate cancer.",
"datePublished": "2024-09-12",
"url": "https://questionsmedicales.fr/article/39264425",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00259-024-06916-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Azolato-Bridged Dinuclear Platinum(II) Complexes Exhibit Androgen Receptor-Mediated Anti-Prostate Cancer Activity.",
"datePublished": "2024-09-11",
"url": "https://questionsmedicales.fr/article/39258898",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.inorgchem.4c01093"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Diagnostic",
"item": "https://questionsmedicales.fr/mesh/D003933"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques et procédures diagnostiques",
"item": "https://questionsmedicales.fr/mesh/D019937"
},
{
"@type": "ListItem",
"position": 4,
"name": "Techniques de diagnostic cardiovasculaire",
"item": "https://questionsmedicales.fr/mesh/D003935"
},
{
"@type": "ListItem",
"position": 5,
"name": "Pléthysmographie",
"item": "https://questionsmedicales.fr/mesh/D010991"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Pléthysmographie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Pléthysmographie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Pléthysmographie",
"description": "Comment la pléthysmographie est-elle utilisée pour le diagnostic ?\nQuels types de pléthysmographie existent ?\nQuels troubles peuvent être diagnostiqués par pléthysmographie ?\nLa pléthysmographie est-elle invasive ?\nQuel est le rôle de la pléthysmographie dans l'évaluation cardiaque ?",
"url": "https://questionsmedicales.fr/mesh/D010991?mesh_terms=Prostatic+Hyperplasia&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Pléthysmographie",
"description": "Quels symptômes peuvent indiquer un besoin de pléthysmographie ?\nLa pléthysmographie peut-elle aider à identifier des symptômes respiratoires ?\nQuels signes cliniques sont évalués par pléthysmographie ?\nLes symptômes de troubles vasculaires sont-ils visibles ?\nComment la pléthysmographie aide-t-elle à comprendre les symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D010991?mesh_terms=Prostatic+Hyperplasia&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Pléthysmographie",
"description": "Comment prévenir les troubles détectés par pléthysmographie ?\nLa pléthysmographie peut-elle aider à la prévention ?\nQuels examens préventifs sont recommandés ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLe stress influence-t-il les résultats de la pléthysmographie ?",
"url": "https://questionsmedicales.fr/mesh/D010991?mesh_terms=Prostatic+Hyperplasia&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Pléthysmographie",
"description": "La pléthysmographie est-elle un traitement ?\nQuels traitements peuvent être envisagés après une pléthysmographie ?\nLa pléthysmographie influence-t-elle le choix du traitement ?\nQuels médicaments peuvent être prescrits après une pléthysmographie ?\nLa rééducation est-elle nécessaire après une pléthysmographie ?",
"url": "https://questionsmedicales.fr/mesh/D010991?mesh_terms=Prostatic+Hyperplasia&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Pléthysmographie",
"description": "Quelles complications peuvent survenir après une pléthysmographie ?\nLa pléthysmographie peut-elle causer des effets secondaires ?\nQuels sont les risques associés à la pléthysmographie ?\nComment gérer les complications potentielles ?\nLes complications sont-elles fréquentes avec la pléthysmographie ?",
"url": "https://questionsmedicales.fr/mesh/D010991?mesh_terms=Prostatic+Hyperplasia&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Pléthysmographie",
"description": "Quels facteurs de risque influencent les résultats de la pléthysmographie ?\nLe diabète est-il un facteur de risque pour la pléthysmographie ?\nL'hypertension impacte-t-elle les résultats de la pléthysmographie ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle dans les risques ?",
"url": "https://questionsmedicales.fr/mesh/D010991?mesh_terms=Prostatic+Hyperplasia&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la pléthysmographie est-elle utilisée pour le diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle mesure les changements de volume pour détecter des anomalies circulatoires ou respiratoires."
}
},
{
"@type": "Question",
"name": "Quels types de pléthysmographie existent ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les types incluent la pléthysmographie des membres, pulmonaire et optique."
}
},
{
"@type": "Question",
"name": "Quels troubles peuvent être diagnostiqués par pléthysmographie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à diagnostiquer des troubles vasculaires, des maladies pulmonaires et des obstructions."
}
},
{
"@type": "Question",
"name": "La pléthysmographie est-elle invasive ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est généralement non invasive et ne nécessite pas d'intervention chirurgicale."
}
},
{
"@type": "Question",
"name": "Quel est le rôle de la pléthysmographie dans l'évaluation cardiaque ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle évalue le flux sanguin et la fonction vasculaire, utile pour les maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un besoin de pléthysmographie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs, des engourdissements ou des problèmes respiratoires peuvent nécessiter cet examen."
}
},
{
"@type": "Question",
"name": "La pléthysmographie peut-elle aider à identifier des symptômes respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle mesure la capacité pulmonaire et peut révéler des anomalies respiratoires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont évalués par pléthysmographie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle évalue les signes de mauvaise circulation, comme l'œdème ou la cyanose."
}
},
{
"@type": "Question",
"name": "Les symptômes de troubles vasculaires sont-ils visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme des varices ou des douleurs peuvent être observés."
}
},
{
"@type": "Question",
"name": "Comment la pléthysmographie aide-t-elle à comprendre les symptômes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle quantifie les changements de volume, fournissant des données sur la gravité des symptômes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles détectés par pléthysmographie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain, faire de l'exercice et éviter le tabac sont essentiels."
}
},
{
"@type": "Question",
"name": "La pléthysmographie peut-elle aider à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet de détecter précocement des problèmes, facilitant des interventions préventives."
}
},
{
"@type": "Question",
"name": "Quels examens préventifs sont recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers de la circulation et de la fonction pulmonaire sont conseillés."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut réduire les risques de troubles circulatoires."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les résultats de la pléthysmographie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la circulation sanguine et les résultats de l'examen."
}
},
{
"@type": "Question",
"name": "La pléthysmographie est-elle un traitement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, c'est un outil de diagnostic qui guide les décisions de traitement."
}
},
{
"@type": "Question",
"name": "Quels traitements peuvent être envisagés après une pléthysmographie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent inclure des médicaments, des interventions chirurgicales ou des thérapies physiques."
}
},
{
"@type": "Question",
"name": "La pléthysmographie influence-t-elle le choix du traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle fournit des informations cruciales pour adapter le traitement aux besoins du patient."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent être prescrits après une pléthysmographie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anticoagulants ou des vasodilatateurs peuvent être prescrits selon les résultats."
}
},
{
"@type": "Question",
"name": "La rééducation est-elle nécessaire après une pléthysmographie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend des résultats; une rééducation peut être recommandée pour améliorer la circulation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une pléthysmographie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares, mais peuvent inclure des ecchymoses ou des douleurs temporaires."
}
},
{
"@type": "Question",
"name": "La pléthysmographie peut-elle causer des effets secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Généralement, elle est sans effets secondaires, mais des réactions cutanées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les risques associés à la pléthysmographie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques sont minimes, mais des infections peuvent survenir si des dispositifs sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications potentielles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consulter un médecin si des symptômes inhabituels apparaissent après l'examen."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes avec la pléthysmographie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elles sont rares et la procédure est généralement bien tolérée par les patients."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent les résultats de la pléthysmographie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, le tabagisme, l'obésité et les antécédents familiaux de maladies vasculaires sont des facteurs."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque pour la pléthysmographie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut affecter la circulation sanguine et influencer les résultats."
}
},
{
"@type": "Question",
"name": "L'hypertension impacte-t-elle les résultats de la pléthysmographie ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hypertension peut altérer la circulation et les mesures de volume."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire augmente le risque de troubles circulatoires."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle dans les risques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies vasculaires augmentent le risque personnel."
}
}
]
}
]
}
This retrospective study assessed the diagnostic accuracy of targeted biopsy (TB) and unilateral systematic biopsy in detecting clinically significant prostate cancer (csPCa) in 222 men with single ma...
Patients underwent multiparametric MRI and MRI/ultrasound fusion TB and 12-needle standard biopsy (SB) from September 2016 to June 2021. The study compared the diagnostic performance of TB + iSB (ipsi...
Among 126 patients with csPCa (ISUP ≥ 2), detection rates for TB + iSB, TB + cSB, and TB were 100, 98.90, and 100% for lesions, respectively. TB + iSB showed the highest sensitivity and negative predi...
TB + iSB improved csPCa detection rates and reduced biopsy numbers, making it a viable alternative to TB + SB for single MRI lesions....
Exosomes secreted by cancer-associated fibroblasts (CAFs) play a critical role in cancer progression. This study aimed to explore the effects of CAF exosomes on prostate cancer (PC) cell metastasis. P...
Androgen dependence is a key feature of prostate cancer, and androgen deprivation is effective in treating prostate cancer. However, the disease often worsens and develops into castration-resistant pr...
An MRI-based risk calculator (RC) has been recommended for diagnosing clinically significant prostate cancer (csPCa). PSMA PET/CT can detect lesions that are not visible on MRI, and the addition of PS...
A total of 683 consecutive biopsy-naïve men who underwent both [...
The prevalence of csPCa was 47.5% (262/552) in the development cohort and 41.9% (55/131) in the temporal validation cohort. In the development cohort, the AUC of MRI-PRIMARY-RC was significantly highe...
The addition of the PRIMARY score to MRI-based multivariable model improved the accuracy of risk stratification prior to biopsy. Our novel MRI-PRIMARY prediction model is a promising approach for redu...
Prostate cancer is an androgen-dependent malignancy that presents a marked treatment challenge, particularly after progression to the castration-resistant stage. Traditional treatments such as androge...
To explore the detection rates of clinically significant prostate cancer (csPCa; ISUP ≥2) in patients with a single MRI lesion that is visible or invisible on transrectal ultrasound (TRUS) during biop...
Retrospective analyses of patients who underwent targeted and systematic biopsy of the prostate for one MRI-visible lesion (PI-RADS score ≥ 3) between 2017 and 2022. TRUS-visibility, PI-RADS score, an...
277 consecutive patients with one MRI-visible lesion were identified. A correlating lesion on TRUS was present in 147/277 (53%). The median age, PSA level, and prostate volume were 68.0 years (IQR: 62...
Bimodal-visible lesions more often harbored csPCa and were easier to target. TRUS-visibility of MRI lesions is an independent predictor of csPCa. Therefore, education in both modalities is essential. ...
Organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 are important hepatic transporters. We previously identified OATP1B3 being critically implicated in the disposition of abiraterone. We aim...
Medical androgen deprivation therapy (ADT) options have expanded for patients with advanced prostate cancer (PC). Historically, ADT was primarily available in long-acting injectable formulations. In 2...
A cross-sectional survey was conducted among US residents aged > 40 years with PC, employing a discrete choice experiment to assess preferences for ADT attributes. For each choice task, respondents we...
A total of 304 respondents completed the survey (mean age 64.4 years). LCA identified four preference groups, named according to the attribute each group considered most important: Sexual interest, Co...
Respondents differed in their preferences regarding ADT attributes, highlighting the need for patient involvement in their treatment decisions. Effective communication between healthcare providers and...
Docetaxel resistance is a significant obstacle in the treatment of prostate cancer (PCa), resulting in unfavorable patient prognoses. Intratumoral heterogeneity, often associated with epithelial-to-me...
To address this, we employed a high-throughput single-cell flow cytometry approach to identify a specific surface fingerprint associated with docetaxel-resistance in PCa cells and complemented it with...
Our approaches revealed a 6-molecule surface fingerprint linked to docetaxel resistance in primary PCa specimens. We observed consistent overexpression of CD95 (FAS/APO-1), and SSEA-4 surface antigens...
In summary, we demonstrate that the identified 6-molecule surface fingerprint associated with docetaxel resistance pre-exists in a subpopulation of primary PCa tumors before docetaxel treatment. Thus,...
Keeping up to date with the latest clinical advances in prostate cancer can be challenging. We investigated the impact of guideline use on quality of treatment decisions as well as the impact of a nov...